Related Experiment Video
Updated: May 1, 2026

Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria
Published on: May 16, 2025
Self-Cascading Copper-Based Nanoassemblies Trigger Bacterial Cuproptosis-Like Death and Promote Wound Healing for
Tianji Feng1,2, Wenjie Fan1, Yin Zhang1
1Eye Center, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Key Laboratory of Ophthalmology, Zhejiang Provincial Clinical Research Center for Eye Diseases, Zhejiang Provincial Engineering Institute on Eye Diseases, Hangzhou 310009, P. R. China.
Abstract:
Diabetes mellitus leads to systemic immunosuppression, increasing susceptibility to persistent infections and elevating the risk of severe complications. Concurrently, multidrug-resistant (MDR) pathogens such as methicillin-resistant Staphylococcus aureus (MRSA) further exacerbate therapeutic difficulties. To address this challenge, we engineered peroxidase (POD)-like nanoassemblies (DC/Cu) through the copper-coordinated self-assembly of ε-poly(L-lysine)-derived carbon dots (CDs) and anti-inflammatory agent diclofenac sodium (DS). These nanoassemblies integrate antibacterial, anti-inflammatory, and tissue-reparative functionalities for the treatment of MDR bacteria-induced diabetic infections. Cationic DC/Cu can selectively adhere to bacterial membranes, enabling microenvironment-responsive spatiotemporal drug release. The POD-like activity of CDs catalyzes the endogenous H2O2, inducing membrane lipid peroxidation and enhancing cell membrane permeability, which facilitates copper influx. This self-cascade induces lethal intracellular copper overload in MRSA, with transcriptomic profiling confirming Cu2+-mediated inhibition of Fe-S cluster proteins and disruption of the tricarboxylic acid cycle, leading to subsequent activation of cuproptosis-like death pathway. Simultaneously, the released DS mitigates the inflammatory response, while Cu2+ facilitates tissue regeneration. MRSA-infected diabetic foot ulcers and diabetic MRSA keratitis models validated DC/Cu's multifunctional efficacy in bacterial eradication, inflammatory mitigation, and tissue regeneration. Collectively, these multifunctional nanoassemblies demonstrate a promising and effective approach for precision therapeutic intervention against MDR pathogen-aggravated diabetic complications.
Insights
New nanoassemblies combat drug-resistant bacteria in diabetes. These engineered particles deliver antibacterial and anti-inflammatory effects, promoting tissue repair for diabetic complications.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Infectious Diseases
Background:
- Diabetes mellitus causes immunosuppression, increasing infection susceptibility and complication severity.
- Multidrug-resistant (MDR) pathogens, like methicillin-resistant Staphylococcus aureus (MRSA), complicate diabetes treatment.
- Diabetic infections require innovative therapeutic strategies addressing both pathogen resistance and host immune dysfunction.
Purpose of the Study:
- To engineer multifunctional nanoassemblies (DC/Cu) for treating MDR bacteria-induced diabetic infections.
- To integrate antibacterial, anti-inflammatory, and tissue-reparative properties into a single therapeutic agent.
- To investigate the mechanism of action of DC/Cu nanoassemblies against MRSA and their efficacy in diabetic models.
Main Methods:
- Copper-coordinated self-assembly of carbon dots (CDs) and diclofenac sodium (DS) to form POD-like nanoassemblies (DC/Cu).
- Assessment of DC/Cu's antibacterial activity, drug release kinetics, and mechanism of MRSA cell death (cuproptosis).
- Evaluation of DC/Cu efficacy in MRSA-infected diabetic foot ulcer and keratitis animal models, assessing bacterial eradication, inflammation, and tissue regeneration.
Main Results:
- DC/Cu nanoassemblies exhibit peroxidase-like activity, catalyzing H2O2 to induce lipid peroxidation and copper influx into MRSA.
- Intracellular copper overload triggers a cuproptosis-like death pathway in MRSA by inhibiting Fe-S cluster proteins and disrupting the tricarboxylic acid cycle.
- DC/Cu effectively eradicated MRSA, reduced inflammation, and promoted tissue regeneration in diabetic infection models.
Conclusions:
- Multifunctional DC/Cu nanoassemblies offer a promising precision therapeutic approach for MDR pathogen-aggravated diabetic complications.
- The engineered nanoassemblies demonstrate synergistic antibacterial, anti-inflammatory, and regenerative effects.
- DC/Cu represents a novel strategy for combating challenging infections in diabetic patients.
More Related Videos
09:15Come to the Light Side: In Vivo Monitoring of Pseudomonas aeruginosa Biofilm Infections in Chronic Wounds in a Diabetic Hairless Murine Model
Published on: October 10, 2017
05:57Author Spotlight: Metallic Nanocomposites to Eliminate Antibiotic-Resistant Bacteria
Published on: October 4, 2024
Related Concept Videos
Bacterial Signaling
Gene Regulation in Microbial Communities: Quorum Sensing
Microbial Corrosion